ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

ARVN Company Profile and Key Details

NASDAQ : ARVN

Arvinas, Inc.

$8.30

-9.26-52.73%

At Close 4:00 PM

67.69

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

ARVN Stock Price Chart

Stock Price Today

Arvinas, Inc. (ARVN) stock declined over -52.73%, trading at $8.30 on NASDAQ, down from the previous close of $17.56. The stock opened at $10.58, fluctuating between $7.91 and $10.78 in the recent session.

Stock Snapshot

17.56

Prev. Close

10.58

Open

570.81M

Market Cap

68.77M

Number of Shares

7.9136

Day Low

10.7758

Day High

-3

P/E Ratio

87.08%

Free Float in %

-2.77

EPS (TTM)

10.8

Book Value

-5.74

Cash Flow per Share

18.98M

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 11, 2025	10.58	10.78	7.91	8.30	18.94M
Mar 10, 2025	18.08	18.45	17.22	17.56	1.12M
Mar 07, 2025	17.97	18.76	17.76	18.28	1.92M
Mar 06, 2025	17.13	18.93	16.97	18.06	1.49M
Mar 05, 2025	16.76	17.70	16.41	17.50	1.21M
Mar 04, 2025	15.99	16.87	15.53	16.52	1.51M
Mar 03, 2025	17.77	18.00	16.21	16.23	1.05M
Feb 28, 2025	17.06	17.70	16.57	17.70	933.29K
Feb 27, 2025	17.15	18.18	16.98	17.26	1.24M
Feb 26, 2025	17.95	17.95	16.61	17.14	1.15M
Feb 25, 2025	16.83	17.74	16.26	17.67	1.65M
Feb 24, 2025	17.73	17.80	16.07	16.75	1.95M
Feb 21, 2025	18.90	19.05	17.35	17.77	1.87M
Feb 20, 2025	18.35	19.15	18.24	18.37	1.04M
Feb 19, 2025	18.50	19.40	18.30	18.54	1.01M
Feb 18, 2025	18.41	20.38	18.40	18.65	1.79M
Feb 14, 2025	17.61	18.32	17.19	18.31	935.38K
Feb 13, 2025	18.15	18.48	17.50	17.67	1.03M
Feb 12, 2025	17.51	18.98	17.36	17.95	1.34M
Feb 11, 2025	18.73	19.19	16.99	17.68	1.86M

Contact Details

New Haven, CT 06511

United States

Website: https://www.arvinas.comContact: 203 535 1456

About Company

Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer (mCRPC); ARV-471, a PROTAC protein degrader targeting the estrogen receptor protein for the treatment of patients with metastatic ER positive/HER2 negative breast cancer; and ARV-766 an investigational orally bioavailable PROTAC protein degrader for the treatment of men with mCRPC. The company has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., and Bayer AG. Arvinas, Inc. was founded in 2013 and is based in New Haven, Connecticut.

Frequently Asked Questions

What is the current Arvinas, Inc. (ARVN) stock price?

Arvinas, Inc. (NASDAQ: ARVN) stock price is $8.30 in the last trading session. During the trading session, ARVN stock reached the peak price of $10.78 while $7.91 was the lowest point it dropped to. The percentage change in ARVN stock occurred in the recent session was -52.73% while the dollar amount for the price change in ARVN stock was -$9.26.

ARVN's industry and sector of operation?

The NASDAQ listed ARVN is part of Biotechnology industry that operates in the broader Healthcare sector. Arvinas, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ARVN?

Mr. Sean A. Cassidy C.P.A., CPA, M.B.A.
Chief Financial Officer, Principal Financial Officer & Treasurer
Mr. Sean A. Cassidy CPA, CPA, M.B.A.
Chief Financial Officer, Principal Financial Officer & Treasurer
Ms. Angela M. Cacace Ph.D.
Senior Vice President of Neuroscience & Platform Biology
Dr. John A. Grosso Ph.D.
Senior Vice President of R&D Technical Operations
Mr. Jeff Boyle
Vice President of Investor Relations
Dr. Ian Taylor Ph.D.
Chief Scientific Officer
Dr. Ronald A. Peck
Chief Medical Officer
Mr. Matthew Batters J.D.
Gen. Counsel & Corporation Sec.
Mr. David Loomis M.B.A.
Vice President, Principal Accounting Officer & Chief Accounting Officer
Dr. Randy Teel Ph.D.
Senior Vice President of Corporation & Bus. Devel.
Mr. Steve Weiss
Senior Vice President & Chief HR Officer
Mr. David K. Loomis M.B.A.
Vice President, Principal Accounting Officer & Chief Accounting Officer
Dr. Ronald A. Peck M.D.
Chief Medical Officer
Dr. John G. Houston Ph.D.
Chairperson, Chief Executive Officer & Pres

How ARVN did perform over past 52-week?

ARVN's closing price is 4.88% higher than its 52-week low of $7.91 where as its distance from 52-week high of $46.51 is -82.2%.

How many employees does ARVN have?

Number of ARVN employees currently stands at 430.

Link for ARVN official website?

Official Website of ARVN is: https://www.arvinas.com

How do I contact ARVN?

ARVN could be contacted at phone 203 535 1456 and can also be accessed through its website. ARVN operates from 5 Science Park, New Haven, CT 06511, United States.

How many shares of ARVN are traded daily?

ARVN stock volume for the day was 18.98M shares. The average number of ARVN shares traded daily for last 3 months was 1.4M.

What is the market cap of ARVN currently?

The market value of ARVN currently stands at $570.81M with its latest stock price at $8.30 and 68.77M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

ARVN Stock Price Chart

Stock Price Today

Stock Snapshot

17.56

Prev. Close

10.58

Open

570.81M

Market Cap

68.77M

Number of Shares

7.9136

Day Low

10.7758

Day High

-3

P/E Ratio

87.08%

Free Float in %

-2.77

EPS (TTM)

10.8

Book Value

-5.74

Cash Flow per Share

18.98M

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 11, 2025	10.58	10.78	7.91	8.30	18.94M
Mar 10, 2025	18.08	18.45	17.22	17.56	1.12M
Mar 07, 2025	17.97	18.76	17.76	18.28	1.92M
Mar 06, 2025	17.13	18.93	16.97	18.06	1.49M
Mar 05, 2025	16.76	17.70	16.41	17.50	1.21M
Mar 04, 2025	15.99	16.87	15.53	16.52	1.51M
Mar 03, 2025	17.77	18.00	16.21	16.23	1.05M
Feb 28, 2025	17.06	17.70	16.57	17.70	933.29K
Feb 27, 2025	17.15	18.18	16.98	17.26	1.24M
Feb 26, 2025	17.95	17.95	16.61	17.14	1.15M
Feb 25, 2025	16.83	17.74	16.26	17.67	1.65M
Feb 24, 2025	17.73	17.80	16.07	16.75	1.95M
Feb 21, 2025	18.90	19.05	17.35	17.77	1.87M
Feb 20, 2025	18.35	19.15	18.24	18.37	1.04M
Feb 19, 2025	18.50	19.40	18.30	18.54	1.01M
Feb 18, 2025	18.41	20.38	18.40	18.65	1.79M
Feb 14, 2025	17.61	18.32	17.19	18.31	935.38K
Feb 13, 2025	18.15	18.48	17.50	17.67	1.03M
Feb 12, 2025	17.51	18.98	17.36	17.95	1.34M
Feb 11, 2025	18.73	19.19	16.99	17.68	1.86M

Contact Details

New Haven, CT 06511

United States

Website: https://www.arvinas.comContact: 203 535 1456

About Company

Frequently Asked Questions

What is the current Arvinas, Inc. (ARVN) stock price?

ARVN's industry and sector of operation?

Who are the executives of ARVN?

How ARVN did perform over past 52-week?

ARVN's closing price is 4.88% higher than its 52-week low of $7.91 where as its distance from 52-week high of $46.51 is -82.2%.

How many employees does ARVN have?

Number of ARVN employees currently stands at 430.

Link for ARVN official website?

Official Website of ARVN is: https://www.arvinas.com

How do I contact ARVN?

ARVN could be contacted at phone 203 535 1456 and can also be accessed through its website. ARVN operates from 5 Science Park, New Haven, CT 06511, United States.

How many shares of ARVN are traded daily?

ARVN stock volume for the day was 18.98M shares. The average number of ARVN shares traded daily for last 3 months was 1.4M.

What is the market cap of ARVN currently?

The market value of ARVN currently stands at $570.81M with its latest stock price at $8.30 and 68.77M of its shares outstanding.

Employees	430
Beta	1.96
Sales or Revenue	$78.50M
5Y Sales Change%	-0.07%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	430
Beta	1.96
Sales or Revenue	$78.50M
5Y Sales Change%	-0.07%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

ARVN Company Profile and Key Details

Arvinas, Inc.

ARVN Stock Price Chart

Stock Price Today

Stock Snapshot

Stock Price History Chart

Contact Details

About Company

Company Information

Frequently Asked Questions

ARVN Stock Price Chart

Stock Price Today

Stock Snapshot

Stock Price History Chart

Contact Details

About Company

Company Information

Frequently Asked Questions